WILLIAM IRVINE, MD
Ophthalmology Physician · JACKSON, TN
Individual Active NPI 1760488498
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 1,236 | 11,435 | $2,888,427 | $1,177,211 | $902,712 |
| 2023 | 1,340 | 7,858 | $3,647,982 | $1,316,060 | $1,013,108 |
| 2022 | 1,466 | 8,453 | $3,915,947 | $1,442,740 | $1,102,076 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 3,120 | $34 | $27 |
| 92134 | Imaging of retina | 1,906 | $36 | $26 |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 1,740 | $34 | $27 |
| 92014 | Established patient complete exam of visual system | 909 | $113 | $80 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 725 | $84 | $55 |
| 67028 | Injection of drug into eye | 535 | $106 | $79 |
| J0178 | Injection, aflibercept, 1 mg | 286 | $830 | $657 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 282 | $118 | $85 |
| J9035 | Injection, bevacizumab, 10 mg | 260 | $71 | $54 |
| J0177 | Injection, aflibercept hd, 1 mg | 248 | $331 | $264 |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 182 | $196 | $156 |
| 67028 | Injection of drug into eye | 151 | $85 | $67 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MD0000024247 | TN |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Tennessee
- NPI 1689653511
- NPI 1760425250
- NPI 1396208781
- NPI 1124241997
- NPI 1396012613
- NPI 1528047586
- NPI 1942790001
- NPI 1447568241
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.